|
Prescription Drug Search
Strengths available for Mabthera vial:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Mabthera:
- Albania
- Algeria
- Argentina
- Armenia
- Aruba
- Azerbaijan
- Bahamas
- Bangladesh
- Bolivia
- Bosnia and Herzegovina
- Cayman Islands
- Chile
- Cyprus
- Denmark
- Ecuador
- Egypt
- El Salvador
- Fiji
- Finland
- Germany
- Gibraltar
- Hungary
- India
- Indonesia
- Ireland
- Japan
- Jordan
- Korea, Republic of
- Latvia
- Mauritius
- Netherlands Antilles
- Panama
- Poland
- Portugal
- Saint Lucia
- Spain
- Sweden
- Trinidad and Tobago
- United Kingdom, UK
- United States, US
Latest news releases on Mabthera:
Cipla drug price cut not to hurt revenue much, say analysts - MoneyControl.com
the analyst says. Swiss pharma major Roche had earlier this year signed a manufacturing deal with India's Emcure Pharma so that its anti-cancer drugs Herceptin and MabThera could be made in India at affordable prices. Analysts say Cipla's move ...
Compulsory licensing sets off a wave of price cuts in cancer drugs - Livemint.com
Roche has decided to reintroduce its Herceptin (trastuzumab) and MabThera (rituximab) drugs in India under new names and lower prices by outsourcing their manufacturing to local drug maker Emcure Pharmaceuticals Ltd. Herceptin and MabThera are currently ...
Rituximab significantly reduces kidney injury in membranous nephropathy - Xagena Medical News
Rituximab ( MabThera, Rituxan ) causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study published in the Clinical Journal of the American Society Nephrology ( CJASN
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth … - Yahoo Finance
NEW YORK, May 10, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0850351/Autoimmune-Disorders-Therapeutics-Market-to-2017---Launch-of-Gilenya-and ...
